(Q34219687)

31 July 2017

title

Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies (English)

1 reference

31 July 2017

Cram P

1

1 reference

31 July 2017

Blitz SG

series ordinal

2

1 reference

31 July 2017

Monto A

series ordinal

3

1 reference

31 July 2017

Fendrick AM

series ordinal

4

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

223-230

1 reference

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

31 July 2017

cites work

1 reference

12 December 2020

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

12 December 2020

The cost-effectiveness of sildenafil

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Effectiveness of influenza vaccine in health care professionals: a randomized trial

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Prevention of influenza in long-term-care facilities. Long-Term-Care Committee of the Society for Healthcare Epidemiology of America

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Clinical features of influenza.

1 reference

12 December 2020

Clinical signs and symptoms predicting influenza infection

1 reference

12 December 2020

Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis

1 reference

12 December 2020

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

12 December 2020

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

1 reference

12 December 2020

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

1 reference

12 December 2020

Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

12 December 2020

Influenza-associated morbidity and mortality in young and middle-aged women

1 reference

12 December 2020

The effectiveness of vaccination against influenza in healthy, working adults.

1 reference

12 December 2020

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

12 December 2020

Influenza pandemic preparedness plan for the United States

1 reference

12 December 2020

Diagnostic testing for influenza: review of current status and implications of newer treatment options

1 reference

12 December 2020

The impact of influenza epidemics on mortality: introducing a severity index.

1 reference

12 December 2020

Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial

1 reference

12 December 2020

The impact of influenza epidemics on hospitalizations.

1 reference

12 December 2020

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

1 reference

12 December 2020

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

1 reference

12 December 2020

Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

12 December 2020

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

12 December 2020

The economic impact of pandemic influenza in the United States: priorities for intervention.

1 reference

12 December 2020

1 reference

12 December 2020

Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

1 reference

12 December 2020

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

12 December 2020

10.2165/00019053-200119030-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1020036310

0 references

1 reference